TechPrecision narrows losses, posts positive EBITDA but faces covenant breach, going-concern

TechPrecision Corporation (OTCMKTS: TPCS) - snapshot

What's happening: management is stabilizing operations - gross margins and EBITDA improved - but the company is running short on liquidity, has breached loan covenants, and reports substantial doubt about going concern until it renews or replaces its revolver and improves Stadco profitability.

Key facts & figures (quarter ended June 30, 2025)
* Revenue: $7,379 (down 8% vs $7,986 in prior year).
* Cost of revenue: $6,349 (down 18% vs $7,747).
* Gross profit: $1,030 vs $239 (gross margin 14.0% vs 3.0%).
* SG&A: $1,493 (vs $1,580).
* Loss from operations: $(463) vs $(1,341) - marked improvement.
* Net loss: $(597) or $(0.06) per share (vs $(1,460) or $(0.16)). Weighted avg shares: 9,757,846.
* EBITDA (non‑GAAP): $239 (vs negative $634 prior year).
* Depreciation & amortization: $701. Interest expense: $135.
* Cash & cash equivalents: $143 (down $52 in the quarter).
* Total available liquidity: $1,856 = $143 cash + $1,949 undrawn revolver capacity + $236 book overdrafts.
* Total debt (principal): $5,770; current portion of long‑term debt (net): $5,714 (long‑term reclassified to current due to covenant breaches).
* Revolver outstanding: $1,664; revolver unused capacity: $1,949.
* Working capital: $(748) (improved from $(1,570) at March 31, 2025).
* Total assets: $32,142; total stockholders' equity: $8,212.
* Contract assets (unbilled less progress payments): $9,077; remaining performance obligations: $50,114 (expected revenue within 36 months).
* Backlog highlights: Ranor backlog $24,402; Stadco backlog $25,712.
* Capital expenditures (quarter): $1,250 (customer‑reimbursed machinery program noted).

Positive takeaways
* Gross margin recovery: margin expanded to 14% from 3% - cost controls and lower loss provisions helped.
* Operating progress: operating loss narrowed substantially (from $(1.34M) to $(0.46M)).
* EBITDA turned positive: $239 for the quarter - shows operations can generate earnings before non‑cash & financing items.
* Cash from operations improved: $646 provided by operating activities (vs $107 prior year).
* Backlog strong: $50.1M remaining performance obligations across Ranor and Stadco supports revenue visibility over next 36 months.

Negative / risks - drawn from income statement and disclosures
* Still unprofitable: net loss $(597) and accumulated deficit $(10,743).
* Liquidity stress & covenant breaches: lender reserves remedies; all long‑term debt reclassified current because of covenant noncompliance.
* Going concern: management discloses substantial doubt - must renew revolver or secure alternative financing by August 29, 2025 (per filing).
* High leverage and near‑term maturities: $5.77M debt with most classified current - limited cushion if bank accelerates.
* Customer concentration: several customers account for large percentages of revenue (Customer C 25%, Customer E 21%, Customer A 15% in the quarter) - a risk to revenue if any major buyer reduces orders.
* Recurring losses at Stadco: Stadco remains the operating drag (negative segment gross profit), and remediation of Stadco performance is a stated requirement for liquidity recovery.
* Internal control weaknesses: five material weaknesses disclosed (purchase accounting, tax accounting, Stadco accounting, impairment testing process, segregation of duties) - audit/controls risk and potential for restatements or delayed reporting.

What to watch next (near term catalysts & risks)
* Revolver renewal / lender action - critical timing and binary for solvency given covenant violations.
* Stadco turnaround - utilization, throughput and margin improvements; management says Stadco profitability is required to remove going concern risk.
* Cash burn vs collections on contract assets and contract liability conversion to revenue (timing of progress payments).
* Any lender waiver or new financing announcements, or equity raises (dilution risk).
* Remediation progress on internal controls - affects reporting reliability and access to capital.

Bottom line
TechPrecision shows operational improvement: margins and EBITDA turned positive and net loss narrowed. But the balance sheet and liquidity picture are the headline risk - covenant breaches, a material going concern disclosure, concentrated customers, and material weaknesses in controls. The company's near‑term survival depends on lender accommodation or new financing and a faster Stadco turnaround. Investors should treat TPCS as a high‑risk, turnaround play until financing and covenant issues are clearly resolved.